Breast and prostate cancer: more similar than different.
about
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indicationsShort-term enzalutamide treatment for the potential remission of active surveillance or intermediate-risk prostate cancer: a case study, review, and the need for a clinical trialDifferential regulation enrichment analysis via the integration of transcriptional regulatory network and gene expression data.Estrogen signaling and the DNA damage response in hormone dependent breast cancers.mRNA expression of steroidogenic enzymes, steroid hormone receptors and their coregulators in gastric cancer.Chitotriosidase, a marker of innate immunity, is elevated in patients with primary breast cancer.Sex steroid metabolism in benign and malignant intact prostate biopsies: individual profiling of prostate intracrinologyAnalysis of tumor suppressor genes based on gene ontology and the KEGG pathway.Estrogen receptor β activation impairs prostatic regeneration by inducing apoptosis in murine and human stem/progenitor enriched cell populations.Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding.Fas Activated Serine-Threonine Kinase Domains 2 (FASTKD2) mediates apoptosis of breast and prostate cancer cells through its novel FAST2 domain.Recent advances in allosteric androgen receptor inhibitors for the potential treatment of castration-resistant prostate cancer.The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytesAssay reproducibility and interindividual variation for 15 serum estrogens and estrogen metabolites measured by liquid chromatography-tandem mass spectrometry.Analysis of candidate genes has proposed the role of y chromosome in human prostate cancer.Estrogen receptors and their implications in colorectal carcinogenesis.Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target?Polygenic modeling of genome-wide association studies: an application to prostate and breast cancer.Slug contributes to cancer progression by direct regulation of ERα signaling pathwayEstrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivityAndrogen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1.Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex.A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate CancerTeasing out the role of aromatase in the healthy and diseased testis.The stromal genome heterogeneity between breast and prostate tumors revealed by a comparative transcriptomic analysis.A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?Multiple roles of COUP-TFII in cancer initiation and progressionIdentification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions.NRBP1 is downregulated in breast cancer and NRBP1 overexpression inhibits cancer cell proliferation through Wnt/β-catenin signaling pathwayRegulators of genetic risk of breast cancer identified by integrative network analysis.A high-fat diet containing whole walnuts (Juglans regia) reduces tumour size and growth along with plasma insulin-like growth factor 1 in the transgenic adenocarcinoma of the mouse prostate model.Estrogen receptors and human disease: an update.Expression of androgen receptor splice variants in clinical breast cancers.Tissue-of-origin-specific gene repositioning in breast and prostate cancer.Androgen regulation of epithelial-mesenchymal transition in prostate tumorigenesisA Drosophila Genome-Wide Screen Identifies Regulators of Steroid Hormone Production and Developmental TimingPhase two steroid metabolism and its roles in breast and prostate cancer patientsSirtuin 1 (SIRT1) and steroid hormone receptor activity in cancerTargeting Akt3 signaling in triple-negative breast cancer.
P2860
Q26996518-51D20F7F-F4E1-4E84-9EE0-33FFB8A70144Q27009177-47FF44FD-E97F-46F6-8570-35F76EBC3D84Q30861497-859C0FE9-6157-445C-BF29-BE4BAA391B78Q33646842-909F609F-100B-49DA-8CEC-C59344C5E59BQ33684994-87C52E64-5584-4819-9B4A-03807F23D5A5Q33919829-6515AE92-73A8-4681-85AF-F735FC30AE7BQ34092890-2ED31019-E04B-4B93-977A-3FD7FDF9AAA8Q34160138-14335257-98B1-487E-A191-9BAB4CAC1BFBQ34342340-6142008B-970B-45CE-8E1C-207A52A18C8FQ34360076-74034E7B-3524-4556-AF2E-CCD9DBD1BB99Q34448585-07C8D76F-1F4C-4FC2-BE23-4091E3CD48F5Q34495028-2B8F7499-410D-4747-AAED-192FFCF70278Q34696040-03BF0E75-B2B5-4B30-BB1F-EABC55E8EC81Q34893614-EF545E21-7DC1-4126-84B1-625128D6CAE5Q35015903-2F78D6B2-B489-45CE-AD7B-A7A8935E8C92Q35037282-46DAF117-3023-4C38-8D33-37FDAE9A2068Q35053261-7249EB54-EA82-4D55-86A4-150027796911Q35074994-275F4202-A7CE-4ADC-B18C-DB28CD51444EQ35168129-477676AA-9914-484C-B503-A6A6360ABECEQ35176093-E46E526A-F88E-4EB0-9ABB-F6297D619DE2Q35176984-8D42D154-E20F-4D6F-9729-940855F3152AQ35595690-5839B657-6E26-4997-9281-4ACAD313716EQ35689627-CE96F555-3992-493E-BC64-70E8F5171F2DQ35733386-503673E7-2315-4C47-9524-58DD958288D4Q35832205-7EA32A6B-79DB-429F-88A2-0ECD3318F532Q36090771-E815F2E1-2EC0-4008-973C-F9EB34C72C58Q36113793-224DC390-0EF0-4CB1-848E-F0ABF4A6CBADQ36312989-8794160E-5D73-4404-A3C7-4063DA30C805Q36331604-4ED84239-4056-46EA-BB19-8BE0F7FB1BF3Q36389827-5C531461-70E4-44A6-BFA1-EB90DD8C928CQ36419747-8029CACA-5945-457C-A87C-B7A9DCD6BDFEQ36443123-A4E7A74F-07CE-489F-B277-164B200A0164Q36661810-6D459FF5-11A4-4E81-8B75-3DB76A58891FQ36689084-7F9F96AE-CDC8-4F5E-A3D9-14FEB5FD9503Q36698100-2D86FFA6-36F4-46E6-B150-0E399EEFE6DEQ36827512-6DCAD737-22EB-44E1-B42E-B50E17AC4618Q37032010-89F057D1-841F-409F-B0CA-8DD9E4263030Q37142561-98409A76-87DF-4017-8ED8-7C87428D5A58Q37244100-83FC5975-EBB8-466E-A98E-C66754B4058DQ37624534-DD0FFA23-4BE3-432D-9B02-F85ABAD0CCF5
P2860
Breast and prostate cancer: more similar than different.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Breast and prostate cancer: more similar than different.
@en
Breast and prostate cancer: more similar than different.
@nl
type
label
Breast and prostate cancer: more similar than different.
@en
Breast and prostate cancer: more similar than different.
@nl
prefLabel
Breast and prostate cancer: more similar than different.
@en
Breast and prostate cancer: more similar than different.
@nl
P2860
P356
P1476
Breast and prostate cancer: more similar than different
@en
P2093
Ian D Davis
Stephen N Birrell
P2860
P2888
P304
P356
10.1038/NRC2795
P407
P577
2010-02-11T00:00:00Z